Top news of the day: Bharat Biotech says COVAXIN shows 81% efficacy in interim analysis; Supreme Court says voicing dissent against government does not amount to sedition, and more
The Hindu
COVAXIN is one of the two vaccines approved for use in the country thus far and is being used as part of the immunisation programme rolled out on January 16. The Drugs Controller General of India (DCGI) had given the emergency use authorisation for the vaccine in clinical trial mode.
More Related News